The OGF–OGFr axis has been identified in several types of cancer tissues, and the effects of its signaling are linked to the immunological modulation of cytokine-releasing cells, which can remodel the tumor microenvironment by enhancing anti-cancer activity and alleviating immunosuppressive action [30]. This evidence concerns the gene PENK and cancer.